This spontaneous report was received from a physician and concerns an patient of an unspecified age and sex 
from Belgium.
The patient's weight, height and medical history were not reported. The patient was treated with golimumab 
(solution for injection, subcutaneous) dose and frequency unspecified, initiated on an unspecified date for an 
unspecified indication. Concomitant medications were not reported. On an unspecified date, the patient had 
developed progressive multifocal leukoencephalopathy. Action taken with golimumab was not reported. The 
outcome was not reported for progressive multifocal leukoencephalopathy.
This report was serious (medically significant).
Print Time: 07-JUN-2016 03:01 PM If a field is blank, there is no data for that field Page 437 of 549
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
Revision to the information was received on 13-MAY-2015.
This case version was created for the purpose of quality improvement. Upon review the following correction was 
made: version created to amend the USPI, Core, IB labeling for the event of progressive multifocal 
leukoencephalopathy from labeled/listed/ to unlabeled/unlisted.